Measuring public health officers' opinions on new vaccination programs by means of the WHO Vaccine Introduction Guidelines

Human Vaccines

Volumn 5, Issue 9, 2009, Pages 640-644

  Marchetti, Federico ^a   Morelli, Paolo ^b  

^a GSK   (Italy)

^b Cros NT   (Italy)

Author keywords

Human papilloma virus; Immunization; Italy; Odds ratio; Questionnaires; Rotavirus; Vaccines; Varicella

Indexed keywords

CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; ROTAVIRUS VACCINE; WART VIRUS VACCINE;

CHICKENPOX; COST EFFECTIVENESS ANALYSIS; FINANCIAL MANAGEMENT; HEALTH PERSONNEL ATTITUDE; HUMAN ROTAVIRUS; ITALY; PAPANICOLAOU TEST; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; REVIEW; VACCINATION; WART VIRUS;

EID: 73649095491     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.9092     Document Type: Review

References (19)

1. Vaccine Introduction Guidelines - Adding a vaccine to a national immunization programme: decision and implementation. WHO/IVB/05.18 Available on the internet at: www.who.int/vaccines-documents/ [accessed 2009].
2. Piano Nazionale Vaccini (aggiornamento 2005). Available on the internet at: www. ministerosalute.it/imgs/C-17-pubblicazioni-543-allegato.pdf [accessed 2009].
3. Consiglio Superiore di Sanità, parere dell'11 gennaio 2007. Available on the internet at: www.epicentro.iss.it/focus/hpv/pdf/CSS-hpv.pdf [accessed 2009].
4. Esposito S, Principi N. Differences in vaccination in European Union. Human Vaccin 2008; 4:313-5.
5. Ferro A, Bertoncello L, Bordigon G. L'Italia frantumata: un Paese, 21 calendari vaccinali. Tendenze Nuove 2008; 5:617-28.
6. Gilca V, Sauvageau C, McNeil S, Gemmill IM, Dionne M, Dobson S, et al. Setting priorities for new vaccination programs by using public health officers and immunization managers opinions. Vaccine 2008; 26:4204-9.
7. Ronco G, Ghisetti V, Segnan N, Snijders PJ, Gillio-Tos A, Meijer CJ, et al. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005; 41:297-305.
8. Capri S, Bamfi F, Marocco A, et al. Impatto clinico ed economico della vaccinazione anti-HPV. Italian Journal Public Health 2007; 4:36-54.
9. Sorveglianza dei Pediatri Sentinella (rete SPES). Available on the internet at: www.spes.iss.it/tab1-2007.htm [accessed 2009].
10. Azzari C, Massai C, Poggiolesi C, Indolfi G, Spagnolo G, De Luca M, et al. Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin 2007; 23:2945-54.
11. Bonanni P, Boccalini S, Bechini A, Banz K. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases. Vaccine 2008; 26:5619-26.
12. Vaccinazioni dell'età pediatrica: coperture vaccinali stimate dal Ministero della Salute sulla base dei riepiloghi inviati dalle Regioni. Available on the internet at: www.ministerosalute. it/malattieInfettive/ documenti/CopVaccPED2007.pdf [accessed 2009].
13. Varicella vaccination overview in European countries. Available on the internet at: www.euvac.net/graphics/euvac/vaccination/var.html [accessed 2009].
14. Recommended Immunization Schedules for Persons Aged 0 - 18 Years - United States. MMWR 2008; 57.
15. Guarino A, Ansaldi F, Ugazio A, Chiamenti G, Bona G, Correra A, et al. Italian Pediatrician's consensus statement on anti-Rotavirus vaccines. Minerva Pediatr 2008; 60:3-16.
16. Marchetti F, Assael B, Gabutti G, Guarino A, Lopalco PL, Marocco A, et al. Monitoring the rate of hospitalization before rotavirus immunization in Italy utilizing ICD9-CM regional databases. Hum Vaccin 2009; 5:172-6.
17. Standaert B, Marocco A, Assael B, et al. Analisi di costo-efficacia della vaccinazione universale in Italia con il vaccino Rix4414 contro i rotavirus. Pharmacoeconomics-Italian Research Articles 2008; 10:23-35.
18. Vesikari T, Van Damme P, Giaquinto C, et al. European Society for Paediatric Infectious Diseases/European Society for Pediatric Gastroenterology, Hepatology and Nutrition. Evidence-based recommendations for rotavirus vaccination in Europe. JPGN 2008; 46:38-48.
19. Vesikari T, Karvonen A, Prymula R, Schuster V, Tejedor JC, Cohen R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomized, double-blind controlled study. Lancet 2007; 370:1757-63.